AIM ImmunoTech, Inc. (AIM)
0.562
+0.02
(+2.99%)
USD |
NYAM |
Apr 16, 16:00
0.5556
-0.01
(-1.14%)
After-Hours: 20:00
AIM ImmunoTech Free Cash Flow : -11.34M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Agenus, Inc. | -77.20M |
| Curis, Inc. | -27.20M |
| Plus Therapeutics, Inc. | -20.84M |
| Windtree Therapeutics, Inc. | -15.12M |
| Halozyme Therapeutics, Inc. | 644.59M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -1.986M |
| Cash from Investing (Quarterly) | -0.095M |
| Cash from Financing (Quarterly) | 2.719M |
| Free Cash Flow Per Share (Quarterly) | -0.6772 |
| Free Cash Flow to Equity (Quarterly) | -4.639M |
| Free Cash Flow to Firm (Quarterly) | -1.69M |
| Free Cash Flow Yield | -105.8% |